ZCL 278

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 2138

CAS [587841-73-4]

MF C21H19BrClN5O4S2
MW 584.89

  • Purity: 98%
  • Soluble in DMSO

ZCL 278


Selective Cdc42 GTPase inhibitor. ZCL 278 specifically targets Cdc42–ITSN interaction and inhibits Cdc42-mediated cellular processes, thus providing a powerful tool for research of Cdc42 subclass of Rho GTPases in human pathogenesis. ZCL 278 reduces the perinuclear accumulation of active Cdc42 in contrast to NSC 23766 (Axon 1578), a selective Rac inhibitor.

Size Unit Price Stock
10 mg €105.00 In Stock
50 mg €405.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...